Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Tharimmune ( (THAR) ) is now available.
Tharimmune, Inc. entered into securities purchase agreements with accredited investors to conduct private placement offerings involving common stock and pre-funded warrants. These offerings, disclosed on November 3, 2025, aim to enhance the company’s financial position and involve strategic advisors receiving warrants, with restrictions on stock sales until a resale registration statement is effective.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 10,802,198
Technical Sentiment Signal: Buy
Current Market Cap: $24.65M
See more insights into THAR stock on TipRanks’ Stock Analysis page.